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The kinetic features of human granulocyte lastase, chymotrypsin, bovine pancreatic hymotrypsin, porcine 
pancreatic elastase and elastomucoproteinase were compared. Amino acyl ester substrates were assayed and 
K,,, and k,, values were defined. Aldehyde analogues of thep-nitroanilide substrates designed for granulocyte 
elastase as optimal for K,,, appeared to be potent inhibitors. Sue-D-Phe-Pro-valinal (K, = 40 PM) was found 
to inhibit granulocyte elastase competitively and specifically when measured with synthetic substrates, and 
the K, was 3 pM with the natural protein substrate, elastin. 
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1. INTRODUCTION 
Various neutral proteinases, such as elastase (EC 
3.4.21.37), CG (chymotrypsin, EC 3.4.21.20) and 
collagenase can be found in the granules of 
polymorphonuclear leukocytes. When released in- 
to the circulation, they are inhibited by plasma 
proteinase inhibitors [1,2]. In the case of inhibitor 
deficiency states or when the inhibitors are con- 
sumed, granulocyte proteinases become uncon- 
trolled and may induce disease states accompanied 
by tissue damage [3]. 
To inhibit granulocyte elastase and CG in vitro, 
peptide chloromethyl ketones [4,5], azapeptides 
[6], peptide boronic acids [7] and fermentation 
products, e.g. elasnin [8] and elastatinal [9,10], 
were successfully applied. 
Abbreviations: EMP, elastomucoproteinase; GE, 
granulocyte elastase; CG, cathepsin G; PE, pancreatic 
elastase; PC, pancreatic chymotrypsin; PhCO-L-Tyr- 
OEt, N+-benzoyl-L-tyrosine ethyl ester; Boc-L-Ala- 
ONP, N-t-butoxycarbonyl-L-alanine p-nitrophenyl 
ester; Z-, benzyloxycarbonyl-; Sue-, succinyl-; Boc-, t- 
butoxycarbonyl-; -NH-Np, p-nitroanilide; Ahx, 
2-aminohexanoic acid 
Our previous results obtained with peptide -NH- 
Np substrates [l l] and the findings of Bajusz et al. 
[12] suggested that the aldehyde analogues of 
substrates having small Michaelis constants (K,,,) 
may be good inhibitors of elastase. 
To test the specificity of the inhibition, the effect 
of inhibitors was investigated on other enzymes as 
well. One of them was EMP, a usual con- 
taminating enzyme of PE preparations [13]. This 
enzyme has both mucolytic and proteolytic activity 
and probably plays a role in the decomposition of 
glycoproteins [ 141. 
2. MATERIALS AND METHODS 
PhCO-L-Tyr-OEt, Boc-L-Ala-ONp and porcine 
PE (EC 3.4.21.11) were products of Sigma (St. 
Louis, MO), and bovine PC (EC 3.4.21.1) was ob- 
tained from Merck (Darmstadt). 
Granulocyte proteinases were isolated from 
human granules. GE was purified according to 
Baugh and Travis [15], while CG was isolated as 
described by Feinstein and Janoff [4]. 
EMP was isolated from elastase crudum [14]. 
Elastin was prepared from human lung [3]. 
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The peptides were synthesized by the usual step- 
wise method [16]. The C-terminal amino acids 
(Ala, Ahx and Val) were reduced in the form of 
their Z-protected 2,5dimethylpyrrazolide deriva- 
tives by LiAlHd [17], then the aldehyde function 
formed was protected as the semicarbazone. After 
decarbobenzoxylation the free amino aldehyde 
semicarbazones were acylated with Z-D-Phe-Pro 
and Z-Pro-D-Phe-Pro, respectively, by using 
the dicyclohexylcarbodiimide/N-hydroxybenzotri- 
azole method [ 181. The Z group of the peptides 
was changed for Sue-, and their aldehyde function 
liberated. The products were homogeneous by 
thin-layer chromatography detected with peptide 
and aldehyde reagents, and by elementary analysis. 
Details of the synthesis will be described elsewhere. 
The effect of inhibitors was measured at 37°C 
with Boc-L-Ala-ONp and PhCO-L-Tyr-OEt 
substrates by monitoring s~~trophotometric~ly 
the changes in absorption at 347.5 and 256 nm, 
respectively. The hydrolysis of Boc-L-Ala-ONp 
was examined in 50 mM phosphate buffer, pH 6.5, 
in 50- 100 FM substrate concentration range, 
whereas that of PhCO-L-Tyr-OEt was investigated 
in 100 mM Tris-HCl buffer, pH 7.6, in the range 
10-50 pM. Enzyme concentration was 10 nM. The 
concentration of inhibitors varied between 0.02 
and 4 mM. When determining Km and kcat, the 
substrate concentration was changed between 1 
and 100 mM and the enzyme concentration be- 
tween 1 and 100~M. 
The inhibition of GE was also examined with 
Sue-D-Phe-Pro-valinal and human lung elastin 
substrate. The decomposition of elastin was 
measured by recording the changes in fluorescence 
intensity of fluorescamine reacted with the 
liberated N-terminus upon hydrolysis of peptide 
bqnds of elastin by GE [ 191. 
Ki inhibitory constant was calculated in the case 
of small molecular mass substrates according to 
Dixon, and by the method of Green and Work 1201 
using elastin substrate. The values of K,,, and kcat 
were determined according to the Lineweaver- 
Burk method. 
3. RESULTS AND DISCUSSION 
In our previous studies of granulocyte elastase 3 
substrates of similar composition appeared to have 
the best Michaelis constant among the investigated 
tri~ptide-NH-Np substrates. These substrates 
contained Boc-D-Phe-Pro- at the N-terminus and 
Ahx-, Val- or Ala-NH-Np at the specificity site; 
their K,,, values were 4.2, 6.1, 8.1 FM, respectively 
[l 11. Therefore 3 tripeptide aldehydes with the 
same sequence and 2 tetrapeptide aldehydes which 
are longer with a Pro- at the N-terminus were syn- 
thesized. To increase the solubility of substrates, 
the Boc- protective group was changed for Sue- at 
the N-terminus. 
The effect of the inhibitors was examined with 
GE, and compared with CG, the pancreatic 
analogues of both enzymes, and with EMP, which 
has chymotrypsin-like specificity. 
Assays on elastase were carried out with Boc-L- 
Ala-ONp, whereas PhCO-L-Tyr-OEt substrate 
was used for PC, CG and EMP. These substrates 
are widely used for the assay of these enzymes 
although the elastase-specific Boc-L-Ala-ONp is 
also hydrolyzed by CG, but at a IO-times lower 
rate than by elastase. PhCO-L-Tyr-OEt, on the 
other hand, is cleaved only by chymotrypsin-type 
proteinases. Table 1 shows the kinetic constants of 
the substrates and table 2 the inhibitor constants 
obtained in the presence of inhibitors. The inhibi- 
tion appeared to be competitive in each case, as 
calculated by the Lineweaver-Burk method. 
Tabie 1 
Kinetic constants (I&,, mM; kcat, s-‘) of granuiocyte and pancreatic proteinases measured with ester substrates 
Substrate 
Boc-L-Ala-ONp 
PhCO-L-Tyr-OEt 
GE 
Ir, k,, 
0.20 2.36 
- - 
PE 
k-m km 
0.45 2.07 
- 
EMP 
Km kc,, 
4.30 2.10 
0.34 1.59 
CG 
Km km 
0.21 0.13 
0.26 20.00 
PC 
Kin kc,, 
1.25 0.90 
0.18 48.30 
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Table 2 
Inhibitory constants (Ki, mM) of granulocyte and pancreatic proteinases measured with 
peptide aldehydes 
Inhibitor GE 
Sue-D-Phe-Pro-alaninal 0.62 
-2-aminohexanal 0.38 
-valinal 0.04 
Sue-Pro-D-Phe-Pro-2aminohexanal 0.07 
-valinal 0.04 
PE EMP CG PC 
0.98 3.40 - - 
2.10 2.10 1.40 2.75 
1.40 3.50 - - 
0.85 1.50 0.90 2.00 
0.52 - - - 
GE and PE were assayed with Boc-L-Ala-ONp, CG, PC and EMP with PhCO-L-Tyr-OEt 
as substrate 
3.1. Elastases 3.3. EMP 
Elastases were inhibited by each of the examined 
inhibitors. The compound containing valinal at the 
C-terminus seemed to be the best for GE. An in- 
hibitory constant of Ki = 50,~M was reported by 
Feinstein et al. [9] using elastatinal and Boc-L-Ala- 
ONp as inhibitor and substrate, respectively. With 
Sue-Ala-Ala-Ala-NH-Np substrate an almost 
lo-times more effective inhibition (Kr = 6.2pM) 
was observed [lo]. 2-Aminohexanal was less effec- 
tive in the tripeptide inhibitor form by one order of 
magnitude. PE is effectively inhibited with 
alaninal. The increase in chain length rendered the 
inhibition more effective. Similar observations 
were reported by Thompson [21] although his Ki 
values are far better than those described in this 
paper. This contradiction may be explained by the 
fact that different compounds and conditions were 
applied in the investigations. In addition, it was 
described that the increase of chain length en- 
hanced both the productivity of enzymes with 
peptide-NH-Np substrates [9,22] as well as the in- 
hibitory capacity of peptide chloromethyl ketones 
15,231. 
EMP, similarly to chymotrypsin, may be in- 
hibited with peptide-2aminohexanals as well as 
with alaninal and valinal, though to a small extent. 
Its inhibition with the examined compounds lies 
between that of PE and PC, as follows from the 
data obtained with the substrates (see table 1). 
3.4. GE 
Sue-D-Phe-Pro-valinal seemed to be specific for 
GE, since chymotrypsins were not inhibited, and it 
was also a lOO-fold weaker inhibitor of PE. This 
was also examined with the high molecular mass 
substrate, human lung elastin. The inhibitory con- 
stant, Ki = 3 pM, was one order of magnitude less 
than that obtained in the presence of the small 
molecular mass substrate. 
We may conclude from the above data that pep- 
tide aldehydes may be efficient and specific in- 
hibitors of GE and probably of other intracellular 
serine proteinases as well. 
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